HCA news from FierceHealthFinance
News
SPOTLIGHT: HCA on acquisition trail
HCA CEO Jack Bovender has made it official--he's on the acquisition trail. The company is looking to acquire a large, urban not-for-profit system with lead position in a fast-growing market, Read more...
Insurer troubles could mean more bad debt for providers
In recent weeks, health insurers have started announcing financial results, and the news hasn't been good. WellPoint, for example, Read more...
Trend: Hospitals requiring upfront cash payments before treatment
Of late, a growing number of hospitals have been insisting on cash payments before they offer high-ticket services to non-emergency patients if they're not sure they'll get paid. While such Read more...
IRS seeking input on instructions for Form 990
As most FierceHealthFinance readers know, the IRS released a redesigned Form 990 last year. The new Form 990, which has sparked much discussion and controversy among not-for-profit healthcare Read more...
Non-profit finances deserve second look
Looked at one way, it's easy to see why an agency like Moody's would be less than enthusiastic about the financial prospects of not-for-profit hospitals. Just consider what's going on in many Read more...
HCA Midwest sticks to five-year investment plan, spending $600M
Five years ago, HCA acquired the 12-hospital Health Midwest for $1.13 billion, renaming it HCA Midwest. As part of the buy, HCA execs promised to make some heavy capital investments in the chain's Read more...
Bad debt savages HCA, LifePoint profits
Two hospital chains checked in with quarterlies over the last week, and they're singing the same song: they've both had their profits socked by bad debt. HCA, for one, reported that its bad debt Read more...
Get more HCA coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies